Skip to content
SPACListing
Browse
ScreenerFilingsMarketDeadlinesSponsorsBanksSectorsLearnPricingWatchlist
AnnouncedNasdaq

GP-Act III Acquisition Corp.GPAT

Class A GPATUnits GPATUWarrants GPATWCIK 0001834526

Cash in trust

$303.0M

$302,970,091

Trust per share

Redemption value

IPO

May 2024

$287.5M raised

Combination deadline

Nov 13, 2026

70 days remaining

Filings on record

80

Latest Aug 14, 2026

Business combination

Target
Not disclosed in an indexed filing
Announced
May 13, 2026

Overview

GP-Act III Acquisition Corp. is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001834526. It completed its initial public offering in May 2024, raising $287.5M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker GPAT, units under GPATU, warrants under GPATW on Nasdaq. The vehicle is sponsored by GP-Act. The mandate targets generalist. Definitive business-combination agreement signed, closing pending.

we intend to focus our search on high potential businesses based in the United States.
The mandate, as stated in the IPO prospectus
GeneralistNorth America

Reading the filings

Arithmetic on what GP-Act III Acquisition Corp. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.

  • Time on the clock

    70 days to the Nov 13, 2026 deadline. Inside ninety days a sponsor has three routes and no others: close, call a shareholder vote to extend (which opens a redemption window and usually costs a monthly contribution into the trust), or liquidate and return the cash. This is the window where redemption arithmetic starts to dominate the share price.

  • Warrant coverage

    Each unit carried one-half of one warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.

  • Underwriting

    Cantor Fitzgerald led the offering. It has been named on 114 SPAC IPOs, book-running 101 of them, and 21.4% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.

Scores

Recomputed 4m ago

Three readings of GP-Act III Acquisition Corp., each an unweighted mean of the components shown beneath it, and each component a percentile against every live SPAC rather than an absolute we invented. They describe the setup, not the merit. How they are built

FOMO

Moderate

How much attention is this vehicle attracting right now?

41/100

  • Filing activity56

    3 in 30 days

  • News coverage0

    0 stories in 30 days

  • Deal freshness67

    announced 114 days ago

Attention is not quality. FOMO rises on news volume and on the market paying above trust, both of which have preceded plenty of disappointments.

Potential

High

How likely is this vehicle to complete a combination, and at what scale?

83/100

  • Lead bank record73

    21.4%

  • Bank franchise87

    114 SPAC mandates

  • Trust scale88

    $303M

  • Stage85

    definitive agreement signed

Potential is about execution, not about the target. It says nothing about whether the eventual deal is worth owning, because the target is usually unknown when the score is computed.

These are derived measures, not ratings of investment merit. They carry no view on the target, no price target and no recommendation, and a high score is not a reason to buy anything.

SEC filing history

Free tier: filings older than 24 hours
  • 10-Q

    Quarterly report

    Accession 0001213900-26-090162

    Aug 14, 2026

    20d ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001604488-26-000091

    Aug 14, 2026

    21d ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001167557-26-000222

    Aug 14, 2026

    21d ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001072613-26-000507

    Jun 5, 2026

    3mo ago

    Open filing
  • SCHEDULE 13G

    Beneficial ownership report (passive)

    Accession 0001326389-26-000040

    Jun 4, 2026

    3mo ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001213900-26-056642

    May 14, 2026

    3mo ago

    Open filing
  • 425

    Business-combination communication

    Accession 0001213900-26-056070

    May 13, 2026

    3mo ago

    Open filing
  • 8-K

    Entry into a material definitive agreement; Submission of matters to a vote of security holders

    Items 1.01, 5.03, 5.07, 9.01 · Accession 0001213900-26-056065

    May 13, 2026

    3mo ago

    Open filing
  • 8-K

    Entry into a material definitive agreement

    Items 1.01, 9.01 · Accession 0001213900-26-055248

    May 12, 2026

    3mo ago

    Open filing
  • 8-K

    Other events

    Item 8.01 · Accession 0001213900-26-053043

    May 7, 2026

    4mo ago

    Open filing
  • DEFA14A

    Additional proxy soliciting material

    Accession 0001213900-26-052797

    May 6, 2026

    4mo ago

    Open filing
  • 8-K

    Submission of matters to a vote of security holders

    Item 5.07 · Accession 0001213900-26-052786

    May 6, 2026

    4mo ago

    Open filing
  • 8-K

    Other events

    Item 8.01 · Accession 0001213900-26-051802

    May 4, 2026

    4mo ago

    Open filing
  • DEFA14A

    Additional proxy soliciting material

    Accession 0001213900-26-049269

    Apr 29, 2026

    4mo ago

    Open filing
  • 8-K

    Submission of matters to a vote of security holders

    Item 5.07 · Accession 0001213900-26-049265

    Apr 29, 2026

    4mo ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001539041-26-000009

    Apr 27, 2026

    4mo ago

    Open filing
  • DEF 14A

    Definitive proxy statement

    Accession 0001213900-26-036417

    Mar 30, 2026

    5mo ago

    Open filing
  • 10-K

    Annual report

    Accession 0001213900-26-034846

    Mar 26, 2026

    5mo ago

    Open filing
  • PRE 14A

    PROXY STATEMENT

    Accession 0001213900-26-031944

    Mar 19, 2026

    5mo ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0000927971-26-000013

    Feb 12, 2026

    6mo ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001213900-25-109975

    Nov 13, 2025

    9mo ago

    Open filing
  • SCHEDULE 13G

    Beneficial ownership report (passive)

    Accession 0000927971-25-000035

    Nov 13, 2025

    9mo ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001072613-25-000600

    Aug 14, 2025

    1y ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001326389-25-000266

    Aug 14, 2025

    1y ago

    Open filing
  • SCHEDULE 13G

    Beneficial ownership report (passive)

    Accession 0001905106-25-000026

    Aug 14, 2025

    1y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001213900-25-075661

    Aug 13, 2025

    1y ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001062993-25-014214

    Aug 12, 2025

    1y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001213900-25-043106

    May 14, 2025

    1y ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001062993-25-009259

    May 13, 2025

    1y ago

    Open filing
  • 10-K

    Annual report

    Accession 0001013762-25-004121

    Mar 28, 2025

    1y ago

    Open filing

GP-Act III Acquisition Corp.: questions answered

What is GP-Act III Acquisition Corp. (GPAT)?

GP-Act III Acquisition Corp. is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001834526. It completed its initial public offering in May 2024, raising $287.5M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker GPAT, units under GPATU, warrants under GPATW on Nasdaq. The vehicle is sponsored by GP-Act. The mandate targets generalist. Definitive business-combination agreement signed, closing pending.

How much does GP-Act III Acquisition Corp. hold in trust?

Approximately $302,970,091, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.

When must GP-Act III Acquisition Corp. complete a merger?

By Nov 13, 2026. If no combination closes by then the sponsor must seek a further extension or wind the vehicle up and return the trust.

What happens if GP-Act III Acquisition Corp. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in GP-Act III Acquisition Corp., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

What tickers does GP-Act III Acquisition Corp. trade under?

Class A shares trade as GPAT on Nasdaq, the units as GPATU, and the warrants as GPATW. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.

Is the trust value the same as the share price for GP-Act III Acquisition Corp.?

No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.

How much dilution do GP-Act III Acquisition Corp.'s founder shares and warrants create?

Each unit also carried one-half of one warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.

Who sponsors GP-Act III Acquisition Corp., and what is their track record?

GP-Act is the sponsor entity, part of the GP-Act franchise. This is the only vehicle we have attributed to that sponsor. Named principals: Antonio Bonchristiano.

Which banks underwrote the GP-Act III Acquisition Corp. IPO?

Cantor Fitzgerald. Cantor Fitzgerald was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.

Is GP-Act III Acquisition Corp. tradeable, and where?

Yes. GPAT returned a live quote of $10.99 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.

Is GP-Act III Acquisition Corp. a good investment?

That is not a question this site answers. GP-Act III Acquisition Corp. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this GP-Act III Acquisition Corp. data come from?

Filings GP-Act III Acquisition Corp. submitted to the SEC under CIK 0001834526: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Sep 4, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.